DR. SAMANTHA ANGELA ROZATI OD
Prescription History 1134965254
Optometrist in Wilmington, DE

Active since July 08, 2024PECOS EnrolledAccepts Medicare Assignment
5301 LIMESTONE RD STE 128, WILMINGTON, DE 19808(302) 239-1933 Get Directions

NPPES record last updated: July 8, 2024. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. SAMANTHA ANGELA ROZATI OD, an active Optometrist specialist practicing in Wilmington, DE. Our medical registry currently tracks 1 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 13 documented patient claims. Among these therapy options, the most frequently utilized medication is Neomycin-Polymyxin-Dexameth, which accounts for 13 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

1
Medication
13
Total Claims
14
30-Day Fills
Neomycin-Polymyxin-Dexameth
Most Prescribed · 13 claims
View details
1 medication · 2024 Medicare Part D
Medicare Part D medications prescribed by DR. SAMANTHA ANGELA ROZATI OD in 2024, with prescription volumes, average cost per fill, and DE state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other DE PrescribersVs. DE Avg
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha13$8.16▼ below DE avg▼ Less than typical

About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾

This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

In 2024, this provider wrote 13 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about a third of the volume of the typical Delaware prescriber of this medication (37.7). Medicare paid an average of $8.16 per fill, versus $10.54 statewide.

How often this provider prescribes it

This provider
13
DE average
37.7

This provider prescribes this medication less often than the average DE prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$8.16
DE average
$10.54

This provider's average cost per fill is below the DE average for this medication.

13.8
30-Day Fills
standardized to 30-day supplies
169
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average DE prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the DE average cost per fill.

About this data. The prescription history for DR. SAMANTHA ANGELA ROZATI OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Wilmington, DE practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among DE prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.